Phospho-MAP3K8 (Ser400) Antibody
-
中文名稱:磷酸化-MAP3K8 (Ser400)兔多克隆抗體
-
貨號:CSB-PA588716
-
規(guī)格:¥2454
-
圖片:
-
其他:
產(chǎn)品詳情
-
產(chǎn)品名稱:Rabbit anti-Homo sapiens (Human) MAP3K8 Polyclonal antibody
-
Uniprot No.:
-
基因名:
-
宿主:Rabbit
-
反應種屬:Human,Mouse,Rat
-
免疫原:Peptide sequence around phosphorylation site of Serine 400(C-Q-S(p)-L-D) derived from HumanMAP3K8.
-
免疫原種屬:Homo sapiens (Human)
-
克隆類型:Polyclonal
-
純化方式:Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
-
濃度:It differs from different batches. Please contact us to confirm it.
-
產(chǎn)品提供形式:Liquid
-
應用范圍:ELISA,IHC
-
推薦稀釋比:
Application Recommended Dilution IHC 1:50-1:100 -
Protocols:
-
儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
相關產(chǎn)品
靶點詳情
-
功能:Required for lipopolysaccharide (LPS)-induced, TLR4-mediated activation of the MAPK/ERK pathway in macrophages, thus being critical for production of the proinflammatory cytokine TNF-alpha (TNF) during immune responses. Involved in the regulation of T-helper cell differentiation and IFNG expression in T-cells. Involved in mediating host resistance to bacterial infection through negative regulation of type I interferon (IFN) production. In vitro, activates MAPK/ERK pathway in response to IL1 in an IRAK1-independent manner, leading to up-regulation of IL8 and CCL4. Transduces CD40 and TNFRSF1A signals that activate ERK in B-cells and macrophages, and thus may play a role in the regulation of immunoglobulin production. May also play a role in the transduction of TNF signals that activate JNK and NF-kappa-B in some cell types. In adipocytes, activates MAPK/ERK pathway in an IKBKB-dependent manner in response to IL1B and TNF, but not insulin, leading to induction of lipolysis. Plays a role in the cell cycle. Isoform 1 shows some transforming activity, although it is much weaker than that of the activated oncogenic variant.
-
基因功能參考文獻:
- these data demonstrate that miR-130b represses vascular inflammation via targeting Tpl2 PMID: 28759810
- Results show that the binding of miR-589-5p to the MAP3K8 3'-UTR inhibits MAP3K8 expression and suppresses CD90+ cancer stem cells characteristics in hepatocellular carcinoma. PMID: 27835990
- RelAp43 interacts with the p105-ABIN2-TPL2 complex and we observe a strong perturbation of this complex in presence of M protein. PMID: 29084252
- miRNA-509-3p mimics or inhibitor transfection tests in KGN cells further confirmed that miRNA-509-3p improved oestradiol (E2) secretion by inhibiting the expression of MAP3K8 PMID: 27002000
- role of p105/Tpl2 signaling in lung homeostasis PMID: 26300007
- rs1042058 GG Crohn's disease -risk polymorphism in TPL2 results in a gain-of-function by increasing TPL2 expression and signalling, thereby amplifying Pattern recognition receptor -initiated outcomes. PMID: 26215868
- MAP3K8 is a direct target of miR-144-3p, and miR-144-3p downregulation is a factor in renal cell carcinoma progression through potentiation of MAP3K8 expression. PMID: 27717821
- Taken together, these results suggest that Cot kinase might play a critical role in Helicobacter pylori type IV secretion apparatus-dependent early IL-8 secretion and CagA-dependent late IL-8 secretion as an alternative signaling molecule in the Erk pathway. PMID: 28361341
- Studies indicate that Tpl2, a MAP3K, participates in a broad range of cancer-related signaling pathways and induces tumorigenesis and progression of many cancers. PMID: 25723737
- the results of the present study demonstrated that the miR-509-3p RCC suppressor was a significant regulator of the MAP3K8 oncogene, suggesting that it may have a potential therapeutic role in the treatment of renal cell carcinoma PMID: 25815776
- findings provide a novel perspective on the role of the IL-33/ST2/COT signaling pathway in supporting cancer-associated inflammation in the tumor microenvironment PMID: 25531326
- structurally versatile active site significantly impacts the design of potent, low molecular weight COT kinase inhibitors PMID: 25918157
- TPL2 mediates the phosphorylation of a fraction of nucleophosmin at threonine 199, an event required for its proteasomal degradation and maintenance of steady-state nucleophosmin levels. PMID: 24998852
- MAP3K8 and miR-17-5p expression were inversely correlated with treatment response PMID: 24819603
- COT interacts with and phosphorylates Pin1 on Ser16. Consequently, Pin1 Ser16 phosphorylation by COT increases cyclin D1 abundance and enhances tumorigenecity of MCF7 cells. PMID: 24265246
- Aberrant expression of A-, B-, and C-RAF, and COT is frequent in PTC; increased expression of COT is correlated with recurrence of PTC. PMID: 25674762
- Tpl2 overexpression and downregulation showed significant stimulatory and inhibitory effects on tumorigenic and metastatic potential of ADI PC cells. PMID: 25274482
- Following epithelial injury, intestinal myofibroblasts sense innate or inflammatory signals and activate, via Tpl2, the cyclooxygenase-2 (Cox-2)-prostaglandin E2 (PGE2) pathway, which are essential for the epithelial homeostatic response. PMID: 25316791
- High MAP3K8 expression affects obesity-induced adipose tissue inflammation without systemic effects. PMID: 24586913
- Tpl2 regulates various inflammatory pathways by activating the ERK mediated MAP kinase pathway in innate immune cells such as macrophages and dendritic cells in humans but not in mice. PMID: 24642963
- Coregulation of TLR2 and TLR6 expression correlating with local processing of versican, a proteoglycan TLR2/6 agonist linked to carcinoma progression. PMID: 24723682
- data indicate that Tpl2 kinase is associated with and contributes to disease progression of clear cell renal cell carcinoma PMID: 23982215
- this report have defined a novel network leading to ERK1/ERK2 activation in cysticfibrosis airway epithelial cells in response to P. aeruginosa that involves both the TPL2 and EGFR protein kinases and contributes to inflammation of CF airways. PMID: 24404585
- MAP3K8 mediates the phosphorylation and repression of IRF3 homodimers to promote greater transcriptional activity through utilization of IRF3:IRF7 heterodimers. PMID: 24275658
- High Tpl2 expression is associated with peritoneal dissemination in gastric tumor. PMID: 23828905
- The protein kinase TPL2 is essential for ERK1/ERK2 activation and cytokine gene expression in airway epithelial cells exposed to pathogen-associated molecular patterns. PMID: 23527104
- Authors report constitutive activation of MAP3K8 kinase-dependent pathways that regulate the magnitude and extent of inflammatory activity of monocytes/macrophages within myeloma niches. PMID: 23252623
- TPL2 was found to antagonize oncogene-induced cell transformation and survival through a pathway involving p53 downstream of cJun N-terminal kinase (JNK) and be required for optimal p53 response to genotoxic stress. PMID: 23533274
- Overexpression of MAP3K8 is associated with early-onset colorectal cancer. PMID: 23322277
- High TPL2 expression is associated with tumor progression. PMID: 23125217
- the role of Tpl2 in GPCR-mediated Ca(2+) signaling and cell migration PMID: 21868363
- Cot protein is responsible for the constitutive Erk1/2 activation in the anaplastic large-cell lymphoma cells. PMID: 21741362
- OPN knockdown chemosensitized MDA-MB-231 cells to CTX, which is dependent on p38 MAPK pathway activation PMID: 21539449
- TPL2 kinase plays a critical role in the promotion of androgen depletion-independent prostate cancer progression. PMID: 21267413
- Oncoprotein Cot1 represses kinase suppressors of Ras1/2 and 1,25-dihydroxyvitamin D3-induced differentiation of human acute myeloid leukemia cells. PMID: 20945381
- identification of MAP3K8 (the gene encoding COT/Tpl2) as a MAPK pathway agonist that drives resistance to RAF inhibition in B-RAF(V600E) cell lines PMID: 21107320
- Tensile strain and magnetic particle force application do not induce MAP3K8 and IL-1B differential gene expression in a similar manner to fluid shear stress in human mesenchymal stem cells. PMID: 20603871
- MAP3 kinase COT1 is up-regulated by 1,25-dihydroxyvitamin D3 in parallel with activated c-jun during differentiation of human myeloid leukemia cells PMID: 20227498
- endogenous Tpl2 promotes efficient murine gammaherpesvirus 68 lytic replication through AP-1-dependent upregulation of RTA expression PMID: 19939924
- Cot protein, expressed in HEK293 cells and immunoprecipitated, was used in a peptide-based substrate screening assay. The results of this assay suggested that Polo-like kinase 1 (Plk1) was a substrate of Cot. PMID: 19804365
- contributes to LMP1-induced NF-kB signaling downstream of TRAF2 PMID: 11932422
- suggest that the activation of different signaling pathways by Cot and other MAP3Ks may be regulated separately and may provide evidence for how such discrimination by one member of this kinase family occurs. PMID: 12138205
- Tpl2 is inhibited by and is a partner of NFkappab p105 PMID: 12667451
- hKSR-2, a new member of the KSR family, negatively regulates Cot-mediated MAP kinase and NF-kappaB pathway signaling PMID: 12975377
- the COOH-terminal domain of wild-type Cot regulates its stability and kinase specific activity PMID: 14517305
- optimal TPL-2 stability in vivo requires interaction with ABIN-2 as well as p105 PMID: 15169888
- Data support a role for MAP3K8 activity in cellular transformation, but suggest that mutational activation of the gene is a rare event in lung cancer. PMID: 15287022
- phosphorylation of Cot at Thr-290 is necessary but not sufficient for full kinase activity in the MEK/ERK pathway PMID: 15466476
- Tpl2/Cot is overexpressed in large granular lymphocyte proliferative disorders but not other T-cell neoplasias. PMID: 15575964
- These results indicate a distinction between TNF Receptor family members CD40 and TNFR1 in their utilization of MAP3Ks, and demonstrate TRAF-dependence of Tpl2 association with the CD40 receptor complex. PMID: 15670770
顯示更多
收起更多
-
亞細胞定位:Cytoplasm.
-
蛋白家族:Protein kinase superfamily, STE Ser/Thr protein kinase family, MAP kinase kinase kinase subfamily
-
組織特異性:Expressed in several normal tissues and human tumor-derived cell lines.
-
數(shù)據(jù)庫鏈接:
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-